Home > Boards > US OTC > Medical - Drugs > Elite Pharmaceuticals (ELTP)

.275 is my add point. Too much history

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Liam00 Member Profile
 
Followed By 11
Posts 445
Boards Moderated 0
Alias Born 06/05/11
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2021 10:47:46 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/2/2021 6:16:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/2/2021 6:14:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 5:31:18 PM
Elite Pharmaceuticals reports FQ2 results Seeking Alpha - 11/15/2021 4:51:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 4:12:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 5:29:36 PM
Elite Pharmaceuticals reports Q1 results Seeking Alpha - 8/16/2021 5:05:15 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:22:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 5:01:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:37:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:31:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:21:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2021 5:16:46 PM
Elite Pharmaceuticals reports FY results Seeking Alpha - 6/14/2021 5:16:14 PM
Annual Report (10-k) Edgar (US Regulatory) - 6/14/2021 5:01:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/19/2021 1:29:31 PM
Elite Pharmaceuticals enters exclusive distribution agreement with Prasco Seeking Alpha - 5/4/2021 10:32:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2021 4:02:41 PM
Elite Pharmaceuticals names Marc Bregman as chief financial officer Seeking Alpha - 4/29/2021 8:56:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/12/2021 6:16:33 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 5:04:10 PM
Elite Pharmaceuticals reports FQ3 results Seeking Alpha - 2/16/2021 4:41:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/16/2021 4:23:16 PM
Liam00   Thursday, 11/12/15 02:18:47 PM
Re: Couch post# 172310
Post # of 364967 
.275 is my add point. Too much history with this stock in the past, it will attenuate down over the coming 4 to 8 weeks, IMO. Nasrat clearly stated that they would not announce the NDA filing, until the FDA accepts it. Impatient traders and some weak hands will pull out. I will be ready to scoop up those shares. I am pretty loaded here, and I have been for a few years now. This stock is about to have a huge reckoning, there will be great rewards to those who keep a large chunk in here.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences